The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 3, 2012, Pages 316-319

  Akin, Mehmet ^a   Balkan, Can ^a   Karapinar, Deniz Yilmaz ^a   Kavakli, Kaan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

ABO blood group; children; normal reference ranges; von Willebrand factor activity

Indexed keywords

RISTOCETIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ANAMNESIS; ARTICLE; BLEEDING; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; BLOOD SAMPLING; BLOOD STORAGE; CHILD; FEMALE; HEALTH SURVEY; HUMAN; MALE; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; HEMORRHAGE; HUMANS; MALE; RISK FACTORS; RISTOCETIN; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84860727030     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611422364     Document Type: Article

References (20)

1. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W.. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet. 1985 ; 37 (1). 89-101 (Pubitemid 15138680)
2. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR.. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987 ; 69 (6). 1691-1695 (Pubitemid 17091627)
3. Souto JC, Almasy L, Muniz-Diaz E, et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2000 ; 20 (8). 2024-2028 (Pubitemid 30644654)
4. Nitu-Whalley IC, Lee CA, Griffioen A, Jenkins PV, Pasi KJ.. Type 1 von Willebrand disease-a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history. Br J Haematol. 2000 ; 108 (2). 259-264 (Pubitemid 30143638)
5. Favaloro EJ, Lillicrap D, Lazzari MA, et al. von Willebrand disorder: laboratory aspects to diagnosis and treatment. Hemophilia. 2004 ; 10 (suppl 4). 164-168 (Pubitemid 40045437)
6. Sadler JE.. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost. 2004 ; 2 (10). 1720-1723 (Pubitemid 40192711)
7. Morelli VM, de Visser MC, van Tilburg NH, et al. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens. Thromb Haemost. 2007 ; 97 (4). 534-541 (Pubitemid 46592929)
8. Miller CH, Haff E, Platt SJ, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost. 2003 ; 1 (10). 2191-2197
9. Akin M, Karapinar YD, Balkan C, Ay Y, Kavakli K. Clin Appl Thromb Hemost. 2010 :
10. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW.. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Am J Clin Pathol. 2005 ; 124 (6). 910-917 (Pubitemid 41740192)
11. Chng WJ, Yip CYC, Baliwag MB, Liu TC.. Differential effect of the ABO blood group on von Willebrand factor collagen binding activity and ristocetin cofactor assay. Blood Coagul Fibrinolysis. 2005 ; 16 (1). 75-78
12. Klarmann D, Eggert C, Geisen C, et al. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents. Transfusion. 2010 ; 50 (7). 1571-1580
13. Gallinaro L, Cattini MG, Sztukowska M, et al. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma vonWillebrand factor. Blood. 2008 ; 111 (7). 3540-3545
14. Jenkins PV, O'Donnell JS.. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?. Transfusion. 2006 ; 46 (10). 1836-1844 (Pubitemid 44435738)
15. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008 ; 14 (2). 171-232 (Pubitemid 351343618)
16. Lethagen S, Hillarp A, Ekholm C, Mattson E, Halldén C, Friberg B.. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes. Thromb Haemost. 2008 ; 99 (6). 1013-1018 (Pubitemid 351810482)
17. Davies JA, Collins PW, Hathaway L, Bowen DJ.. The effect of von Willebrand factor Y/C1584 on in vivo protein level and function, and interaction with ABO blood group. Blood. 2007 ; 109 (7). 2840-2846 (Pubitemid 46482079)
18. Davies JA, Collins PW, Hathaway LS, Bowen DJ.. von Willebrand factor: evidence for variable clearance in vivo according to Y/C1584 phenotype and ABO blood group. J Thromb Haemost. 2008 ; 6 (1). 97-103
19. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost. 2006 ; 4 (4). 766-773
20. Tosetto A, Rodeghiero F, Castaman G, et al. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost. 2007 ; 5 (4). 715-721 (Pubitemid 46563569)